The health edit
NUTRITION & HEALTHY AGING
Can a different diet change your biological age?
A small trial found changes in aging-related biomarkers. What that tells us—and what it leaves unanswered.
RECENTLY PUBLISHED
-
Brown Fat Looked Promising—but Losartan Evidence Is Not Yet Human
A large retrospective imaging study linked greater brown-fat activity with favorable cardiometabolic patterns, while losartan activated brown fat only in cell and mouse experiments.
-
SGLT2 Drugs Reduced Heart-Failure and Kidney Events Across 14 Diabetes Trials
A meta-analysis of 14 placebo-controlled trials found lower relative risks of heart-failure hospitalization, cardiovascular death, and composite kidney outcomes with SGLT2 inhibitors in adults with type 2 diabetes.
-
Continuous Glucose Monitoring Lowered HbA1c Without Insulin in a 283-Person Trial
A 26-week randomized trial found that continuous glucose monitoring improved HbA1c and time in range among adults with type 2 diabetes who were not using insulin.
Recent research, explained
-
SGLT2 Drugs Reduced Heart-Failure and Kidney Events Across 14 Diabetes Trials
A meta-analysis of 14 placebo-controlled trials found lower relative risks of heart-failure hospitalization, cardiovascular death, and composite kidney outcomes with SGLT2 inhibitors in adults with type 2 diabetes.
-
Brown Fat Looked Promising—but Losartan Evidence Is Not Yet Human
A large retrospective imaging study linked greater brown-fat activity with favorable cardiometabolic patterns, while losartan activated brown fat only in cell and mouse experiments.
-
Continuous Glucose Monitoring Lowered HbA1c Without Insulin in a 283-Person Trial
A 26-week randomized trial found that continuous glucose monitoring improved HbA1c and time in range among adults with type 2 diabetes who were not using insulin.
BEHIND THE HEADLINE
A younger biomarker profile isn’t proof of a longer life.
Research reported May 12, 2026 · Small randomized trial · 4 weeks
In a trial of 104 adults aged 65–75, several diet changes improved a biological-age estimate based on 20 biomarkers. The clearest statistical signal came from the omnivorous, higher-carbohydrate group.
The important limit: the trial did not establish longer life or fewer diseases. It excluded people with conditions including type 2 diabetes and cancer, so the findings cannot simply be applied to everyone.
From Let’s Talk Health
Full articles from 2025 onward on food, movement, and healthy aging.
-
Brown Fat Looked Promising—but Losartan Evidence Is Not Yet Human
A large retrospective imaging study linked greater brown-fat activity with favorable cardiometabolic patterns, while losartan activated brown fat only in cell and mouse experiments.
-
SGLT2 Drugs Reduced Heart-Failure and Kidney Events Across 14 Diabetes Trials
A meta-analysis of 14 placebo-controlled trials found lower relative risks of heart-failure hospitalization, cardiovascular death, and composite kidney outcomes with SGLT2 inhibitors in adults with type 2 diabetes.
-
Three Lab Values Were Linked to Mortality Risk—but the Score Is Not Yet Ready for Clinical Use
A large U.S. observational study linked the EASIX laboratory score with mortality, but it has not been validated for routine CKM risk screening.
-
Continuous Glucose Monitoring Lowered HbA1c Without Insulin in a 283-Person Trial
A 26-week randomized trial found that continuous glucose monitoring improved HbA1c and time in range among adults with type 2 diabetes who were not using insulin.
-
Higher Paternal BMI Was Linked to Sperm DNA Methylation Differences
A human observational study links paternal BMI and age with sperm DNA methylation patterns, without proving effects on children.
-
Coffee Stayed Steady—but Creamer Added More Calories
A national analysis found stable coffee intake but rising calories from add-ins, led by non-dairy creamer.
Curiosity.
With perspective.
Health headlines move quickly. Research briefs should link to their sources, identify the kind of evidence, and explain what remains unknown.
Human trials, observational studies, and animal experiments answer different questions. Promising findings deserve attention—and careful interpretation.